---
title: "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026"
id: da535f3c-ba6e-4d88-860a-6824cc044dbe
authority: uk
place: "United Kingdom"
applies_also_from: []
kind: regulation
in_force: true
publisher_url: https://www.legislation.gov.uk/uksi/2026/702
attribution: "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
solon_url: https://solon.orangecat.ch/law/da535f3c-ba6e-4d88-860a-6824cc044dbe
language: en
in_force_from: 2026-07-20
date_basis: publisher
status: consolidated
source_url: https://www.legislation.gov.uk/uksi/2026/702/data.xml
read_on: 2026-11-10
sha256: 166f4b1248b3148b0eac3ad1d4a21f30d388275cc10f7bef56daa33b2578de57
provisions: 3
---

# The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026

## Title and introductory text {#prelims}

2026 No. 702
NATIONAL HEALTH SERVICE, ENGLAND
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026
Made
at 9.47 a.m. on 29th June 2026
Laid before Parliament
at 3.30 p.m. on 29th June 2026
Coming into force
20th July 2026
The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006.

## 1 Citation, commencement, extent and application {#regulation-1}

(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026.
(2) These Regulations come into force on 20th July 2026.
(3) These Regulations extend to England and Wales and apply to England only.

## 2 Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 {#regulation-2}

(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals) is amended as follows.
(2) In paragraph (2)—
(a) omit “or” at the end of sub-paragraph (ae); and
(b) after sub-paragraph (ae), insert—
(af) a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by—
(i) Neisseria meningitidis groups A, C, W and Y bacteria, or
(ii) Neisseria meningitidis group B bacteria,
if the conditions set out in paragraph (3) are satisfied;
(ag) a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or
.
(3) In paragraph (3A), for “to (ae)” substitute “to (ag)”.